Charles Sturt University
Graham Centre for Agricultural Innovation

Soo Liang Ooi

 Soo Liang Ooi

BMath, BHSc (Comp Med), MMath, MBA

Rice Bran Arabinoxylan Compound and quality of life of cancer patients

Rice bran arabinoxylan compound (RBAC) is a plant-based biological response modifier for enhancing depleted immune system during and after cancer treatment. Current evidence suggests RBAC may potentially improve cancer patients’ quality of life (QoL).

This research proposes to conduct a pilot feasibility trial to evaluate the effects of RBAC on cancer patients’ QoL, compared to placebo, using a validated questionnaire. Other outcome measures include body mass index and inflammatory-nutritional index. and cytokines profile. The study intends to measure changes in the cytokines profile and to explore the potential effects of RBAC on the gut microbiota of cancer patients compared to placebo.

Read more about a current clinical trial of Rice Bran Arabinoxylan Compound (RBAC) and quality of life of cancer patients.

Top of page


Daiwa Pharmaceutical Co., Ltd., Japan

Top of page


    Find out about current publications on Charles Sturt Research Output

Top of page